Stauber and NextFerm sign sales and distribution agreement for astaxanthin ingredient
Stauber Inc. and NextFerm Technologies have signed a sales and distribution agreement for NextFerm’s fermented astaxanthin ingredient Astaferm.
Photo © AdobeStock.com/ExQuisine
Stauber Inc. (Fullerton, CA) and NextFerm Technologies (Yokneam Illit, Israel) have signed a sales and distribution agreement for NextFerm’s fermented astaxanthin ingredient Astaferm.
“This announcement represents a significant stage in our long-term plan to take the leading position in the astaxanthin market. We believe that working alongside Stauber would accelerate the growth of our product across all categories,” says Boaz Ny, CEO of NextFerm Technologies.
“Astaferm is an outstanding product. It has a compelling story and a technology that places it above and beyond generic astaxanthin offerings today. We already see great interest in what we are offering across many products and applications” says Monica Mitchell, Stauber’s vice president of strategic brands sales and marketing.
Yili to pilot Xampla’s microscopic natural biopolymer capsules for nutrient fortification
July 17th 2024Xampla, a manufacturer natural biopolymers, has announced a partnership with Yili Innovation Centre Europe to test and validate Xampla’s microscopic natural biopolymer capsules used to fortify a range of products with vitamins and nutrients.
